四月 2026
- Home
- Guardant Health
四月 2026的Guardant Health市场份额分析
Guardant Health is an American biotechnology company based in Palo Alto, California. Co-founders Helmy Eltoukhy and AmirAli Talasaz serve as co-chief executive officers.
Guardant Health(包含公司地区分支机构)
查看更多网站流量和参与度信息- guardanthealth.com
Guardant Health收入截至 四月 2026为 500M - 1B
Guardant Health主要域名产生的收入
3 年中Guardant Health主要域名的收入
Guardant Health主要域名的收入
四月 2026的Guardant Health股票价格
Guardant Health的股票交易代码为 GH。您可以在下面查看过去 12 个月的Guardant Health股票表现(最多 四月 2026)
Guardant Health热门域名的总访问量
了解Guardant Health市场份额和潜在市场覆盖范围。
过去 3 个月的总访问量
子公司明细
Guardant Health热门域名的平均访问时长
分析Guardant Health参与度指标。
过去 3 个月的平均访问时长
子公司明细
Guardant Health热门域名的平均页面浏览量
了解Guardant Health如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。
过去 3 个月的平均页面浏览量
子公司明细
想要获取更深入的流量洞见?
过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。
Guardant Health 的新闻与信号
借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。
新闻Guardant Health is developing companion diagnostics for oncology on Apr 30th '26.NEW YORK - Guardant Health announced on Thursday that it has entered into a multi-year strategic collaboration with biopharma company Nuvalent to develop and potentially commercialize companion diagnostics for oncology.
四月 30, 2026阅读更多
新闻Guardant Health is developing companion diagnostics and support potential commercialization of targeted cancer therapies using the.Guardant Health announces multi-year strategic collaboration with Nuvalent to develop companion diagnostics and support potential commercialization of targeted cancer therapies using the Guardant Infinity(TM) platform.
四月 30, 2026阅读更多
新闻Guardant Health partnered with Nuvalent, Inc. on Apr 30th '26.PALO ALTO, Calif.-(BUSINESS WIRE)- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced a multi-year strategic collaboration with Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, to support the development and potential commercialization of Nuvalent's oncology pipeline using the tissue and liquid offerings of the Guardant Infinity(TM) platform.
四月 30, 2026阅读更多
查看 Guardant Health 的所有信号
让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。
